Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05442840 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluation of Pharmacist Intervention for Individuals With Uncontrolled Type 2 Diabetes

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 3 months later Dec 2026 → Apr 2027
See other at-risk trials from University of Manitoba

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Dec 2026 to Apr 2027
    • Eligibility criteria expanded, about 12 words
    • Secondary endpoints: details revised at 3 of 4 entries
    • Publications: details revised at 11 of 12 entries
  2. Primary and study completion pushed from Jun 2026 to Dec 2026v12
  3. Primary and study completion dates: Oct 2025 to Jun 2026v11
  4. Re-verified, no change to tracked fieldsv10
  5. Primary and study completion dates: Mar 2025 to Oct 2025v9
Show 7 earlier versionsHide 7 earlier versions
  1. Primary and study completion dates: Oct 2024 to Mar 2025v8
  2. Primary completion date: Jan 2024 to Oct 2024
    • Study completion date: Mar 2024 to Oct 2024
    v7
  3. Re-verified, no change to tracked fieldsv6
  4. Primary endpoint revised
    • Secondary endpoints: details revised at 1 of 4 entries
    v5
  5. Primary endpoint revisedv4 Show 5 more changesShow less
    • Trial status: Recruiting to Active, Not Recruiting
    • Primary completion date: Jul 2023 to Jan 2024
    • Study completion date: Oct 2023 to Mar 2024
    • Eligibility criteria revised
    • Site details revised
  6. Primary completion date: Apr 2023 to Jul 2023
    • Study completion date: Apr 2023 to Oct 2023
    • Secondary endpoints: details revised at 3 of 4 entries
    v3
  7. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
University of Manitoba
108 trials monitored
See 7 trials at risk
Diabetes
5,087 trials monitored
See 222 trials at risk
Type 2 Diabetes
2,231 trials monitored
See 111 trials at risk
Type 2 diabetes is a chronic disease that can lead to a number of complications if uncontrolled and there is a projected increase of 33% patients living with diabetes over the next 10 years. There can be improvements to modifiable risk factors such as diet and exercise, in addition to medications. Treatment often involves a multidisciplinary approach with a physician, endocrinologist, dietitian, pharmacist and other support health professionals as required. This study will evaluate the effects of the pharmacists (or pharmD interns) intervention, looking at changes to the patients HbA1C, which is a measure of the patients blood glucose control over the previous 3 months as well as the patients understanding and comfort with managing their own diabetes via participant survey.
Trial Details
NCT Number NCT05442840
Lead Sponsor University of Manitoba
Conditions
(from sponsor)		 Diabetes Type 2
Related terms Diabetes Mellitus, Type 2
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov